Orantinib

Overview

Orantinib is a multiple receptor tyrosine kinase inhibitor with IC50s of 2.1 μM, 8 nM and 1.2 μM for VEGF-R1, PDGF-Rβ and FGF-R1, respectively. It has greatest potency against PDGFR autophosphorylation.

Application

Products > Drug Discovery > Inhibitor | Products > Drug Discovery > Inhibitor | Neurological Disease | FGFR

Product Information

• Catalog No.: B0084-409435
• CAS No.: 252916-29-3
• Molecular Formula: C18H18N2O3
• Molecular Weight: 310.35
• Purity: ≥98%
• Storage: Store at -20°C
• Solubility: Soluble in DMSO (Slightly), Methanol (Slightly)

Source

Original product source